The Global Softgel Capsules Market was valued at US$ 7.03 billion in 2021 and is predictable to reach US$ 11.52 billion by 2030 which is projected to attain a CAGR of 5.6 % during the forecast period from 2021- 2030.
Softgel Capsules are oral dosage form for medicine similar to capsules. It consists of a gelatin-based shell with a liquid fill or semi-solid center. The shells are a combination of water, gelatin, opacifier, and plasticiser which includes sorbitol & glycerin.
The increasing prevalence of chronic diseases such as cardiovascular diseases, rising health consciousness among the consumers, and increasing demand for the nutraceuticals industry are the reasons attributed to the growth of the softgels market during the forecast period. In addition, the advancement and growth of pharmaceuticals are also reflected as an attractive opportunity to favor market expansion. Improved bioavailability, its non-reactive nature, enhancing absorption time of drug molecules, easy swallowing, and longer shelf life are the major advantages influencing its wide acceptance.
Softgels capsules are majorly preferred for the patients and geriatric population having indigestion and drug intake in other forms. Such capsules are made in numerous shapes such as oval, oblong, suppository, round among others to attract children and patients. However, high price volatility and low stability of softgel capsules with water-soluble compounds hinder the market growth. Furthermore, increasing research and developments in the pharmaceuticals market and rising health consciousness among the consumers and sports nutrition is expected to create a lucrative opportunity for the global softgel capsules market during the forecast period.
The Global Softgel Capsules Market is segmented by type, application, manufacturers, and region. Based on type, it is categorized into gelatin capsules and non-animal softgel capsules. By application, it bifurcates into anti-anemic preparations, antibiotic & antibacterial drugs, health supplements, antacids & anti-flatulent preparations, anti-inflammatory drugs, cough & cold preparations, vitamin & dietary supplements. Softgel capsules manufacturers are bifurcated into nutraceuticals companies, contract manufacturing organizations, pharmaceutical companies, and cosmeceutical companies. Based on regional insights, the global softgel capsules market is categorized into North America (US, Canada, Mexico, Rest of America), Asia Pacific (India, China, Rest of Asia Pacific), Europe (UK, Germany, Russia, Rest of Europe) and Rest of the world (Latin America and Middle East & Africa).
North American region accounts for the highest market share owing to the presence of numerous key players in the region and approvals and regulations from the U.S. FDA among others gathers huge customer base in the other regions. The European region also holds considerable growth owing to huge investment towards research and development for soft gelatin capsules in the region during the forecast period. Asia Pacific region is projected to deliver the highest CAGR owing to the huge prevalence of patients suffering from several chronic ailments, the growing geriatric population in the region, rising indispensable incomes among the consumer.
Prominent players inducing the Global Softgel Capsules Market are Sirio Pharma Co. Ltd., Strides Pharma Science Ltd., Patheon, Eurocaps, Capsugel, Soft gel Technologies Inc., Fuji Capsules Co. Ltd., CAPTEK Softgel International Inc., EuroCaps Ltd., Curtis Health Caps, Catalent Inc., Aenova Holding GmbH, and Procaps Laboratories among others.
Segmentation and Scope of the Global Softgel Capsules Market
Global Softgel Capsules Market is segmented by type, application, manufacturers, and region.
Rest of World
Middle East & Africa
Prominent players in the Global Softgel Capsules Market among other includes